Camurus
Develops long-acting medicines for severe chronic diseases using advanced drug delivery.
CAMX | ST
Overview
Corporate Details
- ISIN(s):
- SE0007692850 (+2 more)
- LEI:
- 5493003S6Z6VI7WYFQ06
- Country:
- Sweden
- Address:
- Ideon Science Park, 223 70 Lund
- Website:
- https://www.camurus.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Camurus is a science-led international biopharmaceutical company focused on developing and commercializing innovative, long-acting medicines for severe and chronic diseases. Leveraging its expertise in advanced drug delivery systems, the company aims to improve treatment outcomes and quality of life for patients. Camurus' development pipeline and commercial products target significant unmet medical needs in therapeutic areas including diseases of the central nervous system, rare diseases, endocrinology, oncology, and supportive care.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Camurus and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-17 07:00 |
Earnings Release
|
Swedish | 923.9 KB | |
| 2025-07-17 07:00 |
Quarterly Report
|
English | 916.2 KB | |
| 2025-07-01 11:30 |
Regulatory News Service
Camurus’ Oczyesa® receives marketing authorization for treatment of acromegaly …
|
English | 184.9 KB | |
| 2025-07-01 11:30 |
Earnings Release
Camurus meddelar EU-godkännande av Oczyesa® för behandling av akromegali
|
Swedish | 182.4 KB | |
| 2025-06-30 07:00 |
Declaration of Voting Results & Voting Rights Announcements
Förändring av antalet aktier och röster i Camurus
|
Swedish | 130.6 KB | |
| 2025-06-30 07:00 |
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in Camurus
|
English | 141.7 KB | |
| 2025-06-18 08:00 |
Regulatory News Service
Camurus’ POSITANO study shows treatment effects with CAM2029 in polycystic live…
|
English | 168.7 KB | |
| 2025-06-18 08:00 |
Regulatory News Service
Camurus studie POSITANO visar behandlingseffekt av CAM2029 i patienter med poly…
|
Swedish | 167.8 KB | |
| 2025-06-03 19:45 |
M&A Activity
Camurus and Lilly ingår samarbets- och licensavtal avseende långtidsverkande in…
|
Swedish | 169.9 KB | |
| 2025-06-03 19:45 |
Regulatory News Service
Camurus and Lilly enter collaboration and license agreement for long-acting Flu…
|
English | 171.3 KB | |
| 2025-05-27 21:30 |
Transaction in Own Shares
Camurus styrelse utnyttjar återköpsbemyndigande för säkerställande av bolagets …
|
Swedish | 135.3 KB | |
| 2025-05-27 21:30 |
Share Issue/Capital Change
Camurus’ Board of Directors exercises authorization for repurchase of shares fo…
|
English | 141.2 KB | |
| 2025-05-27 18:50 |
Post-Annual General Meeting Information
Resolutions at the annual general meeting 2025 in Camurus
|
English | 155.3 KB | |
| 2025-05-27 18:50 |
Post-Annual General Meeting Information
Beslut vid Camurus årsstämma 2025
|
Swedish | 152.1 KB | |
| 2025-05-15 07:00 |
Quarterly Report
|
Swedish | 695.2 KB |
Automate Your Workflow. Get a real-time feed of all Camurus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Camurus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-17 | Torsten Malmström | Other | Sell | 10,000 | 6,806,400.00 SEK |
| 2024-06-17 | Jon Uguzne Garay Alonso | Other | Other | 33,750 | N/A |
| 2024-05-14 | Torsten Malmström | Other | Sell | 1,495 | 844,675.00 SEK |
| 2024-05-10 | Annette Mattsson | Other | Sell | 1,000 | 550,000.00 SEK |
| 2023-12-15 | Annette Mattsson | Other | Other | 1,000 | 169,500.00 SEK |
| 2023-09-18 | Annette Mattsson | Other | Sell | 1,000 | 294,600.00 SEK |
| 2023-09-06 | Maria Lundqvist | Other | Other | 381 | N/A |
| 2023-08-23 | Maria Lundqvist | Other | Sell | 77 | 22,610.28 SEK |
| 2023-08-23 | Maria Lundqvist | Other | Sell | 58 | 17,032.86 SEK |
| 2023-08-23 | Maria Lundqvist | Other | Other | 77 | 13,051.50 SEK |
